This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Retinal Endo Vascular Surgery for Central Retinal Vein Occlusion

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2006 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
Information provided by:
Hadassah Medical Organization Identifier:
First received: October 3, 2006
Last updated: NA
Last verified: September 2006
History: No changes posted
Patients with Central Retinal Vein Occlusion will undergo vitrectomy, a small needle of about 71 micron will enter a branch retinal vein and TPA will be injected into the obstracted vein.

Condition Intervention
Central Retinal Vein Occlusion Procedure: Retinal endo vascular surgery

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • Visual acuity
  • Amount of macular edema.

Estimated Enrollment: 10
Study Start Date: October 2006
Estimated Study Completion Date: October 2007
Detailed Description:

Patients with Central Retinal Vein Occlusion less than 6 month duration and reduction of vision to 6/21 will go OCT and FANG examinations.

Patient will be operated vitrectomy, and a branch retinal vein will be punctured by small needle and rTPA 200mcg/ml will be injected to the vein.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • crvo less than 6 month
  • Visual Acuity less than 6/21
  • No prior eye surgery except cataract.

Exclusion Criteria:

  • Retinal/iris neovascularization
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00383773

Contact: Michael Halpert, MD. 00972507874385
Contact: Hadas Lemberg, PhD 0097226777572

Sponsors and Collaborators
Hadassah Medical Organization
Study Chair: Michael halpert Hadassah Medical Organization
  More Information Identifier: NCT00383773     History of Changes
Other Study ID Numbers: 1yumbo-HMO-CTIL
Study First Received: October 3, 2006
Last Updated: October 3, 2006

Keywords provided by Hadassah Medical Organization:
retinal vein occlusion

Additional relevant MeSH terms:
Retinal Vein Occlusion
Retinal Diseases
Eye Diseases
Venous Thrombosis
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases processed this record on August 18, 2017